JD Supra: Mergers

FEBRUARY 10, 2025

All indications appear to point toward a robust market for health care mergers and acquisitions (M&A) in the coming year. Inflation finally appears to be easing. With that, we may continue to see interest rate cuts from the Federal Reserve.

Private Equity 165

Private Equity Equities Mergers and Acquisitions M&A 165

JD Supra: Mergers

SEPTEMBER 25, 2023

USAP”), and the private equity firm Welsh, Carson, Anderson & Stowe (“Welsh Carson”), which created USAP, executed a multi-year anticompetitive scheme to consolidate anesthesiology practices in Texas, drive up the price of anesthesia services provided to Texas patients and boost their own profits. Anesthesia Partners, Inc.

Private Equity 288

Private Equity Equities Profitability Trading 288

JD Supra: Mergers

NOVEMBER 14, 2024

Private equity (PE) sponsors often provide incentives to founders, equity holders, employees, directors, and officers of portfolio companies in the form of rollover equity or incentive equity to align their interests with those of the sponsors. By: Goodwin

Equities 165

Equities Private Equity Portfolio 165

JD Supra: Mergers

FEBRUARY 13, 2025

After a subdued 2023 during which it was challenging for private equity (PE) to raise debt financing as a result of elevated interest rates and a difficult syndicated lending market, 2024 featured a material shift in the global credit landscape. By: Akin Gump Strauss Hauer & Feld LLP

Private Equity 170

Private Equity Equities Finance Finance 170

TechCrunch: M&A

DECEMBER 16, 2024

The company's spyware, dubbed Graphite, is capable of hacking phones and stealing private communications. 2024 TechCrunch. All rights reserved. For personal use only.

Private Equity 335

Private Equity Equities Mergers and Acquisitions Securities 335

JD Supra: Mergers

AUGUST 15, 2024

California’s Senate Appropriations Committee will hold a hearing on California’s private equity bill, AB 3129, on August 15, 2024. This proposed legislation would expand existing California Attorney General authority to include review and approval authority over most healthcare private equity transactions. By: BakerHostetler

Private Equity 183

Private Equity Equities Healthcare 183

JD Supra: Mergers

AUGUST 19, 2024

California is looking to take the lead on regulating private equity deals in the health care space by introducing bill AB 3129, which requires private equity groups or hedge funds to receive the state attorney general’s approval before purchasing a health care entity. and may encourage other states to establish similar legislation.

Private Equity 188

Private Equity Equities Funds 188

JD Supra: Mergers

OCTOBER 17, 2023

USAP”) and its private equity sponsor, Welsh, Carson, Anderson & Stowe (“Welsh Carson”) alleging an anticompetitive scheme to consolidate anesthesiology practices in Texas through a series of systematic roll-ups; price setting arrangements; and a market allocation agreement to dominate the anesthesia market in Texas.

Private Equity 276

Private Equity Equities Acquisitions Trading 276

JD Supra: Mergers

JUNE 3, 2024

Private equity firms can breathe a sigh of relief after a federal judge dismissed claims that threatened to establish a precedent for holding private equity firms liable for certain actions by their portfolio companies. By: Troutman Pepper

Private Equity 177

Private Equity Equities Portfolio 177

JD Supra: Mergers

FEBRUARY 14, 2025

Technology continued to be an industry of particular focus for private equity (PE) through 2024. Blackstones $16 billion acquisition of data center platform Airtrunk was the largest deal of Q3 2024, according to Ernst & Young data, and tech deals accounted for 40% of all private equity deployment by value in the third quarter.

Private Equity 171

Private Equity Equities Accountant Acquisitions 171

JD Supra: Mergers

MARCH 12, 2025

private equity market. Read our latest insights into the U.S. We cover monthly deal activity and size, fundraising, exits, leveraged loans, and a look ahead. PE dealmaking had a slower start in 2025. YTD deal numbers through February were below those for the same period in the past five years. By: Ropes & Gray LLP

Private Equity 183

Private Equity Equities 183

JD Supra: Mergers

JANUARY 9, 2024

As we begin 2024, we have highlighted the issues and trends that private equity (PE) investors should consider when evaluating transactions in the healthcare sector. W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity.

Private Equity 201

Private Equity Healthcare Equities Funds 201

JD Supra: Mergers

MARCH 12, 2024

The year 2023 will be remembered as a challenging one for private equity (PE), with complexities to navigate on many fronts. Although overall transaction volume was significantly down, private equity funds still found. By: Akin Gump Strauss Hauer & Feld LLP

Private Equity 197

Private Equity Equities Debt Valuation 197

JD Supra: Mergers

FEBRUARY 28, 2024

Traditionally, private equity firms were seen as benign investors from an antitrust perspective. This is changing. In the past 12 months, PE-funded acquisitions have faced progressively more rigorous scrutiny by antitrust authorities. By: Allen & Overy LLP

Private Equity 192

Private Equity Equities Funds Investors 192

JD Supra: Mergers

MARCH 25, 2025

AIM Equity Partners has made a majority-control growth investment in AMOpportunities (AMO), according to a news release. By: McGuireWoods LLP

Equities 152

Equities Private Equity Healthcare Investment 152

JD Supra: Mergers

JUNE 4, 2024

Private equity sponsors can exhale: A federal court recently stopped the Federal Trade Commission's (FTC) antitrust action that targeted private equity sponsor Welsh, Carson, Anderson & Stowe for the healthcare "roll-up" strategy of its anesthesia practice management portfolio company. The case, Federal Trade Commission v.

Private Equity 188

Private Equity Healthcare Equities Portfolio 188

JD Supra: Mergers

SEPTEMBER 9, 2024

By: Troutman Pepper

Private Equity 177

Private Equity Equities Mergers and Acquisitions M&A 177

JD Supra: Mergers

SEPTEMBER 23, 2024

On August 31, the last day of its 2024 Legislative Session, the California Legislature approved Assembly Bill 3129 (Wood), which provides for notification to and review by the Attorney General of health care transactions involving private equity groups and hedge funds. Governor Newsom is expected to sign the legislation in September.

Private Equity 171

Private Equity Equities Healthcare Funds 171

JD Supra: Mergers

AUGUST 2, 2024

Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. By: Venable LLP

Private Equity 171

Private Equity Healthcare Equities Investment 171

JD Supra: Mergers

AUGUST 23, 2024

The term “rollover equity” is frequently used in discussions about the sale of middle market companies (which often is described as meaning companies with enterprise values from $10 million to $1 billion[1]), but frequently is not well understood by people selling middle market companies (particularly founder or family-owned companies).

Middle Market 165

Middle Market Equities M&A Sale 165

JD Supra: Mergers

SEPTEMBER 26, 2024

The California Legislature recently passed Assembly Bill 3129 (“AB 3129” or the “Bill”), which, if signed by California Governor Gavin Newsom, would increase oversight of healthcare entity transactions involving private equity investment. Governor Newsom has until September 30, 2024, to sign or veto the Bill. By: Arnall Golden Gregory LLP

Private Equity 177

Private Equity Healthcare Equities Investment 177

JD Supra: Mergers

DECEMBER 13, 2024

Episode 12: Exploring Consolidation and Private Equity Investment in Physician Practice Management - In this episode of BRight Minds in Healthcare Delivery, host Eric Tower interviews Robert Aprill, a partner at Physician Growth Partners. Eric and Robert examine private equity (PE) investment in physician services, including various.

Private Equity 165

Private Equity Equities Investment Management 165

JD Supra: Mergers

MARCH 8, 2024

Private equity is squarely in the cross hairs of regulators; the Department of Justice Antitrust Division, the Federal Trade Commission, and the U.S. Department of Health and Human Services recently announced the launch of a joint inquiry into private equity ownership in the health care field. By: Ballard Spahr LLP

Private Equity 192

Private Equity Equities Acquisitions Trading 192

JD Supra: Mergers

DECEMBER 30, 2024

Financial Conduct Authority has published a final report commissioned from Europe Economics to evaluate the potential impacts of implementing a pre-trade equities consolidated tape in the U.K., together with an update responding to the findings of the report. By: A&O Shearman

Equities 177

Equities Economics Trading 177

Sun Acquisitions

APRIL 25, 2025

Increased capital gains taxes can have a far-reaching impact on the business landscape, with ripple effects extending to various sectors, including private equity and venture capital (PE/VC) investments in mergers and acquisitions (M&A).

Private Equity 100

Private Equity M&A Capital Investment 100

JD Supra: Mergers

AUGUST 5, 2024

The Massachusetts legislative session for 2024 has come to a close without the passage of a bill that would have targeted private equity in healthcare.

Private Equity 171

Private Equity Healthcare Equities Funds 171

JD Supra: Mergers

JANUARY 9, 2025

Launching a private equity fund is an exciting yet daunting endeavor; and a General Partner (GP) Advisory Board can be a critical asset in navigating the complexities. Thoughtfully designing and engaging a GP Advisory Board strengthens a private equity firms capabilities by adding external expertise to the firms internal resources.

Private Equity 165

Private Equity Advisory Equities Funds 165

JD Supra: Mergers

AUGUST 29, 2024

Driven by a growing wave of enforcer skepticism toward further healthcare consolidation, some state legislatures have begun to propose “mini-HSR” laws explicitly targeting healthcare transactions involving private equity firms or sponsors. By: Morgan Lewis

Private Equity 171

Private Equity Healthcare Equities 171

JD Supra: Mergers

JANUARY 10, 2025

As some packed the skis and headed to their favorite slopes this winter season, it is hard not to see the analogies to the healthcare private equity (PE) transaction market as we ring in the New Year. Much like the Northern Rockies, there should be plenty of dry powder to support a robust dealmaking environment in 2025.

Private Equity 165

Private Equity Healthcare Equities IT 165

JD Supra: Mergers

AUGUST 1, 2024

Private equity investment in health care has grown significantly over the past two decades, and the US government is starting to pay attention. The False Claims Act (FCA) appears to be the first avenue of enforcement, but private equity firms should be prepared for state. By: K&L Gates LLP

Private Equity 177

Private Equity Equities Medical Government 177

JD Supra: Mergers

MAY 30, 2024

The Federal Trade Commission’s (FTC) push against private equity roll-ups has hit a snag. Judge Hoyt found that the FTC had not adequately alleged that Welsh Carson “is violating” or “is about to violate” antitrust laws, as required under.

Private Equity 188

Private Equity Equities Trading 188

JD Supra: Mergers

FEBRUARY 17, 2025

The California legislature has introduced a bill that would implement some of the same restrictions on private equity health care investments as last years AB 3129. By: Polsinelli

Private Equity 171

Private Equity Equities Management Investment 171

JD Supra: Mergers

AUGUST 1, 2024

At the end of last year, Holland & Knight predicted that "the current enforcement environment will continue into 2024 and will focus heavily on the healthcare industry, along with private equity transactions or 'roll-ups.' 15, 2023.)

Private Equity 171

Private Equity Healthcare Equities 171

JD Supra: Mergers

JANUARY 17, 2025

On January 14, 2025, the Department of Justice (DOJ) sued private equity giant KKR & Co. KKR) for numerous violations of antitrust law, alleging that KKR repeatedly violated its obligations to provide information on its acquisitions as required by the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). By: Goodwin

Private Equity 177

Private Equity Equities Acquisitions IT 177

JD Supra: Mergers

OCTOBER 15, 2024

According to EY’s Private Equity Pulse, Q2 2024 was the strongest quarter in two years, with 122 announced transactions at a valuation of $196 billion total enterprise value. This seems to be the case, as we see initial signs of an improving landscape after a stronger Q2. But the US PE market is. By: Woodruff Sawyer

Private Equity 177

Private Equity Equities Insurance Valuation 177

JD Supra: Mergers

OCTOBER 1, 2024

Gavin Newsom vetoed a controversial bill that would have restricted private equity and hedge fund healthcare transactions in the state. On Saturday, September 28, California Gov. By: Fenwick & West LLP

Private Equity 165

Private Equity Healthcare Equities Funds 165

JD Supra: Mergers

FEBRUARY 26, 2025

Private equity (PE) investment in the U.S. healthcare sector faces a complex and evolving regulatory and legislative landscape. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns about market consolidation, quality of care, corporate profiteering and lack of financial transparency. By: Benesch

Private Equity 188

Private Equity Healthcare Equities Investment 188